Search

everythinglearnresearchcommunity

for

Search:↓

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Spironolactone does not increase the risk of breast cancer recurrence.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Effective monitoring and prevention strategies are needed to manage the spread of hand, foot, and mouth disease in children.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Finasteride use may increase the risk of male breast cancer.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Men had worse COVID-19 outcomes than women in New York City.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Male pattern baldness may predict prostate cancer risk.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

People with alopecia areata are more likely to have other immune-related conditions.